例句與造句

1. FLAP is necessary for the activation of 5-lipoxygenase and therefore for the production of leukotrienes, 5-hydroxyeicosatetraenoic acid, 5-oxo-eicosatetraenoic acid, and specialized pro-resolving mediators of the lipoxin and resolvin classes.
2. However, the most studied and accepted role for FPR2 receptors is in mediating the actions of the cited lipoxins and resolvins in dampening and resolving a wide range of inflammatory reactions ( see lipoxin, Epi-lipoxin, and resolvin ).
3. The mechanism behind the resolvin's inhibitory effects on them in not clear but may be indirect and involve at least in certain cases the activation of a GPRs located on the neruons or nearbymicroglia and / or astrocyte cells of the nerve tissue.
4. Resolvin E1 ( RvE1 ), RvD2 ( see resolvins ), neuroprotectin D1 ( NPD1 ), and maresin 1 ( Mar1 ) are metabolites of the omega 3 fatty acids, eicosapentaenoic acid ( for RvE1 ) or docosahexaenoic acid ( for RvD2, NPD1, and Mar1 ).
5. Resolvin D1 ( RvD1 ), a metabolite of the omega 3 fatty acid, docosahexaenoic acid, is a member of the specialized proresolving mediators ( SPMs ) class of metabolites that function to resolve diverse inflammatory reactions and diseases in animal models and, it its proposed, humans.
6. It's difficult to find resolvin in a sentence. 用resolvin造句挺難的
7. At least 6 members of the D series of resolvins ( RvDs ) viz ., RvD1, RvD2m AT-RVD1, RvD3, AT-RvD3, and RvD5, activate their target cells through this receptor; these results have led to naming GPR32 the RVD1 receptor ( see Resolvin # Mechanisms of Action ).
8. Resolvin D2 ( RvD2 ), a member of the specialized proresolving mediators ( SPM ) class of polyunsaturated fatty acid metabolites, is an activating ligand for GPR18; RvD2 and its activation of GPR18 contribute to the resolution of inflammatory responses as well as inflammation-based and other diseases in animal models and are proposed to do so in humans.
9. A major function for FPR2 is binding certain specialized pro-resolving mediators ( SPMs ), i . e . lipoxin ( Lx ) A4, and AT-LxA4 ( metabolites of arachidonic acid ) as well as resolvin D1 ( ReVD ) 1, ReVD2, and AT-RevD1 ( metabolites of docosahexaenoic acid ) and thereby to mediate these metabolites activities in inhibiting and resolving inflammation ( see Specialized pro-resolving mediators ).
10. *Resolvin Ds ( RvDs ), i . e . RvD-1, RvD2, RvD3, RvD4, RvD5, and RvD6 ( see resolvin and specialized proresolving mediators # DHA-derived Resolvins ) and protetin Ds ( PDs ), i . e . PD1, PDX, 20-hydroxy-PD1, 17-epi-PD1, and 10-epi-PD1 ( see neuroprotectin D1 and specialized proresolving mediators # DHA-derived protectins / neuroprotectins ).
11. *Resolvin Ds ( RvDs ), i . e . RvD-1, RvD2, RvD3, RvD4, RvD5, and RvD6 ( see resolvin and specialized proresolving mediators # DHA-derived Resolvins ) and protetin Ds ( PDs ), i . e . PD1, PDX, 20-hydroxy-PD1, 17-epi-PD1, and 10-epi-PD1 ( see neuroprotectin D1 and specialized proresolving mediators # DHA-derived protectins / neuroprotectins ).
12. Specialized pro-resolving mediators are cell-derived metabolites of certain polyunsaturated fatty acids viz . : arachidonic acid which is metabolized to the lipoxins; eicosapentaenoic acid which is metabolized to the Resolvin E's; docosahexaenoic acid which is metablized to the Resolvin D's, Maresins, and Neuroprotectins; and n-3 docosapentaenoic acid which is metabolized to the n-3 docosapentaenoic acid-derived resolvins and n-3 docosapentaenoic acid-derived neuroprotectins ( See Specialized pro-resolving mediators ).
13. Specialized pro-resolving mediators are cell-derived metabolites of certain polyunsaturated fatty acids viz . : arachidonic acid which is metabolized to the lipoxins; eicosapentaenoic acid which is metabolized to the Resolvin E's; docosahexaenoic acid which is metablized to the Resolvin D's, Maresins, and Neuroprotectins; and n-3 docosapentaenoic acid which is metabolized to the n-3 docosapentaenoic acid-derived resolvins and n-3 docosapentaenoic acid-derived neuroprotectins ( See Specialized pro-resolving mediators ).
14. For example, ALOX5 and ALOX15 or, alternatively, ALOX5 and ALOX12 can act serially to metabolize arachidonic acid into lipoxins ( see 15-hydroxyicosatetraenoic acid # Further metabolism of 15 ( S )-HpETE, 15 ( S )-HETE, 15 ( R )-HpETE, 15 ( R )-HETE, and 15-oxo-ETE and lipoxin # Biosynthesis ) while ALOX15 and possibly ALOX15B can act with ALOX5 to metabolize eicosapentaenoic acid to resolvin D's ( see resolvin # Production ).
15. For example, ALOX5 and ALOX15 or, alternatively, ALOX5 and ALOX12 can act serially to metabolize arachidonic acid into lipoxins ( see 15-hydroxyicosatetraenoic acid # Further metabolism of 15 ( S )-HpETE, 15 ( S )-HETE, 15 ( R )-HpETE, 15 ( R )-HETE, and 15-oxo-ETE and lipoxin # Biosynthesis ) while ALOX15 and possibly ALOX15B can act with ALOX5 to metabolize eicosapentaenoic acid to resolvin D's ( see resolvin # Production ).
16. FPR2 is also known as the LXA4 or ALX / FPR2 receptor based on studies finding that is a high affinity receptor for the arachidonic acid metabolite, lipoxin A4 ( LXA4 ), and thereafter for a related arachidonic acid metabolite, the Epi-lipoxin, aspirin-triggered lipoxin A4 ( i . e . ATL, 15-epi-LXA4 ) and a docosahexaenoic acid metabolite, resolvin D1 ( i . e . RvD1 ); these three cell-derived fatty acid metabolites act to inhibit and resolve inflammatory responses.
更多例句：  下一頁